News | Radiation Dose Management | March 30, 2017

Connecticut Hospital Association and Bayer to Form First Statewide Radiation Dose Management Repository

Use of Bayer's Radimetrics Enterprise Platform will allow physicians and patients to benchmark radiation exposure across certain medical procedures

Bayer, Radimetrics Enterprise Platform, radiation dose management, Connecticut Hospital Association, statewide repository

March 30, 2017 — The Connecticut Hospital Association (CHA) and Bayer announced an alliance to establish the United States' first-ever statewide radiation dose management repository for patients undergoing certain radiological procedures. The repository will use Bayer’s Radimetrics, a radiation and contrast dose management and analytics tool which provides clinicians with data needed for them to help ensure their patients receive the lowest radiation dosage necessary. The goal is for clinicians to be able to share the data in order to benchmark radiation exposure.

Patients often undergo multiple diagnostic imaging procedures involving radiation – frequently in different provider locations – making it difficult to know the cumulative dose they have received. While the amount of radiation to which each person is exposed depends on his or her specific medical condition, rare circumstances of prolonged, high-dose exposure to radiation could have adverse effects on patients. These risks include skin erythema (reddening), skin tissue injury and birth defects following in-utero exposure.[i] Additionally, radiation can potentially increase the risk of longer term effects such as cancer.[ii] Keeping track of radiation dosage across procedures may help identify these risks and allow physicians to take steps to reduce patient exposure. By benchmarking radiation dosage throughout the CHA network of hospitals and the state of Connecticut, CHA and Bayer hope patients in the future will be empowered to track their own radiation exposure. 

"Connecticut hospitals are national leaders in implementing innovative solutions to achieve patient safety," said Jennifer Jackson, CEO, CHA. "This alliance with Bayer is another example of that leadership. We are very proud to be the first state in the nation to adopt a project that will allow patients and their doctors to measure and closely manage the levels of radiation required for effective imaging and diagnosis."

Giving the lowest appropriate dose of radiation to make a diagnosis is important for patient safety. The repository will provide clinicians with a tool to assist in evaluating the optimal radiation dosage for patients.

In the coming months, hospitals in Connecticut will use Bayer's Radimetrics Enterprise Platform to collect and analyze data at the statewide level. This information will allow providers to benchmark radiation dosage, pursue quality improvements and develop standard clinical practices.

"Connecticut hospitals are committed to improving patient safety, which includes promoting patients' rights to understand their own medical records," said Mary Cooper, M.D., JD, senior vice president of clinical services, CHA. "The alliance with Bayer will empower patients."

Utilizing data from certain imaging studies, the repository will maintain radiation dose information when patients visit participating CHA member institutions for diagnostic procedures.

For more information: www.bayer.us

 

References

[i] U.S. Food & Drug Administration. What are the Radiation Risks from CT? Available at: http://www.fda.gov/Radiation-EmittingProducts/RadiationEmittingProductsandProcedures/MedicalImaging/MedicalX-Rays/ucm115329.htm. Updated February 27, 2017. Accessed March 27, 2017.

[ii] World Health Organization. Ionizing radiation, health effects and protective measures. Available at: http://www.who.int/mediacentre/factsheets/fs371/en/. Updated April 2016. Accessed March 27, 2017.

Related Content

Sponsored Content | Case Study | Enterprise Imaging | November 16, 2018
Centricity Clinical Archive Analytics uses Microsoft Azure and Power BI Embedded to derive intelligence from the data
Feature | November 16, 2018 | By Greg Freiherr
For the first time at the RSNA meeting, vendors of interventiona
Podcast | Interventional Radiology | November 16, 2018
For the first time at the RSNA meeting, vendors of interventional products will have a dedicated area in which to dis
Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Life Image and Mendel.ai Bringing Artificial Intelligence to Clinical Trial Development
News | Artificial Intelligence | November 15, 2018
Life Image and Mendel.ai announced a new strategic partnership that will facilitate the adoption and enhancement of...
News | Enterprise Imaging | November 14, 2018
Konica Minolta Healthcare Americas Inc. will showcase new features and tools for the Exa Enterprise Imaging platform at...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
SuperSonic Imagine Introduces Aixplorer Mach 30 Ultrasound at The Liver Meeting
Technology | Ultrasound Imaging | November 14, 2018
SuperSonic Imagine recently exhibited at The Liver Meeting, held Nov. 9-13 in San Francisco, where the company...